Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ · Healthcare
Acadia Pharmaceuticals Inc. Net Income 2009–2025
Acadia Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2009 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Acadia Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was 3.6 M, a 80.84% decrease year-over-year.
- Acadia Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was 121.1 M, a 590.52% increase year-over-year.
- Acadia Pharmaceuticals Inc. annual net income for 2025 was 391.0 M, a 72.66% increase from 2024.
- Acadia Pharmaceuticals Inc. annual net income for 2024 was 226.5 M, a 469.50% decrease from 2023.
- Acadia Pharmaceuticals Inc. annual net income for 2023 was -61.3 M, a 71.62% decrease from 2022.
- Acadia Pharmaceuticals Inc. annual net income for 2022 was -216.0 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Acadia Pharmaceuticals Inc. Net Income — FAQ
Acadia Pharmaceuticals Inc. (ACAD) net income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Acadia Pharmaceuticals Inc.'s net income?
Acadia Pharmaceuticals Inc. (ACAD) reported net income of $391M for fiscal 2025.
Where can I see ACAD's net income history?
The chart and table above show Acadia Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.